Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
19 March 2026
Pharmaceuticals: Deals revival
19 March 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
12 March 2026
Pharma: Key UK legal developments from 2025
12 February 2026
Corporate Crime 360: Your complete guide to APAC trends in 2026
12 February 2026
UPC Court Fees
11 February 2026
2026 Employment and Workplace Relations in Australia Legal Guide
15 January 2026
Two and a half years of the UPC – Trends and turning points
19 December 2025
Treasury Updates Merger Rules
19 December 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
19 December 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
31 October 2025
High bar for material adverse change in M&A: Lessons from the Mayne Pharma / Cosette decision
18 September 2025
Are you cyber ready? The cyber challenge through the eyes of Australia’s legal leaders
Key contacts
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London
Natalie Bryce
Partner, Brisbane